Former Wells Fargo & Co. and Johnson & Johnson employees are pushing to keep a pair of novel health benefits cases alive following court dismissals by using COBRA recipients to support allegations the companies paid unnecessarily high drug costs in their plans.
The workers brought the two high-profile cases against the employers in July 2024 and February 2024, respectively, arguing they’re breaching their fiduciary duties under the Employee Retirement Income Security Act by paying elevated costs to their pharmacy benefit manager, Express Scripts.
The amended lawsuits are seen as a bellwether for employers who sponsor their own health plans, and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.